A Study of Enzastaurin in Patients With Leukemia

• Status: Completed
• Trial end date: 2008-09-01

Summary

The primary objective of this study is to see if enzastaurin affects the pGSK3 beta level in B-cell chronic lymphocytic leukemia (B-CLL) cells.

• Phase: Phase 1

Details

• Lead Sponsor: Eli Lilly and Company